PMC:7161517 / 1129-1375 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":137,"end":140},"obj":"Body_part"},{"id":"T5","span":{"begin":193,"end":196},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":".\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associated with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, which results in activation of anti-inflammatory"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"T12","span":{"begin":94,"end":102},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":".\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associated with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, which results in activation of anti-inflammatory"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":48,"end":51},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T8","span":{"begin":215,"end":225},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":".\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associated with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, which results in activation of anti-inflammatory"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T15","span":{"begin":137,"end":140},"obj":"Chemical"},{"id":"T16","span":{"begin":193,"end":196},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"}],"text":".\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associated with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, which results in activation of anti-inflammatory"}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":3,"end":23},"obj":"Sentence"},{"id":"T9","span":{"begin":25,"end":35},"obj":"Sentence"},{"id":"T10","span":{"begin":36,"end":93},"obj":"Sentence"},{"id":"T11","span":{"begin":94,"end":141},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":".\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associated with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, which results in activation of anti-inflammatory"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T32","span":{"begin":39,"end":47},"obj":"SP_7"},{"id":"T33","span":{"begin":73,"end":80},"obj":"UBERON:0000948"},{"id":"T34","span":{"begin":94,"end":104},"obj":"SP_7"},{"id":"T35","span":{"begin":125,"end":129},"obj":"G_3;PG_10;PR:000003622"},{"id":"T36","span":{"begin":149,"end":153},"obj":"G_3;PG_10;PR:000003622"},{"id":"T37","span":{"begin":154,"end":158},"obj":"PR:000036013"},{"id":"T15393","span":{"begin":39,"end":47},"obj":"SP_7"},{"id":"T97887","span":{"begin":73,"end":80},"obj":"UBERON:0000948"},{"id":"T56833","span":{"begin":94,"end":104},"obj":"SP_7"},{"id":"T99319","span":{"begin":125,"end":129},"obj":"G_3;PG_10;PR:000003622"},{"id":"T59141","span":{"begin":149,"end":153},"obj":"G_3;PG_10;PR:000003622"},{"id":"T38767","span":{"begin":154,"end":158},"obj":"PR:000036013"}],"text":".\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associated with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, which results in activation of anti-inflammatory"}

{"project":"LitCovid-PubTator","denotations":[{"id":"44","span":{"begin":125,"end":129},"obj":"Gene"},{"id":"45","span":{"begin":94,"end":104},"obj":"Species"},{"id":"46","span":{"begin":39,"end":47},"obj":"Disease"},{"id":"47","span":{"begin":73,"end":92},"obj":"Disease"},{"id":"50","span":{"begin":149,"end":153},"obj":"Gene"},{"id":"51","span":{"begin":154,"end":160},"obj":"Gene"}],"attributes":[{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"Gene:59272"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Tax:2697049"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:C000657245"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:D006331"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Gene:59272"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Gene:284"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":".\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associated with cardiac involvement. SARS-CoV-2 requires binding to ACE2 in the RAS.\n• The ACE2/Ang1-7/Mas pathway counterbalances the RAS, which results in activation of anti-inflammatory"}